J. Mulligan

发表

BRCA1 regulates IFN-gamma signaling through a mechanism involving the type I IFNs.

P. Mullan, Julia J. Gorski, D. Harkin, 2007, Molecular cancer research : MCR.

Identification of Tubulin as the Molecular Target of Proapoptotic Pyrrolo-1,5-benzoxazepines

G. Campiani, D. Williams, D. Zisterer, 2006, Molecular Pharmacology.

Generation of a non-small cell lung cancer transcriptome microarray

Gavin R. Oliver, P. Johnston, R. Kennedy, 2008, BMC Medical Genomics.

BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after Chemotherapy

P. Johnston, P. Mullan, D. Harkin, 2007, Clinical Cancer Research.

A molecular basis for Estrogen Receptor- α deficiency in BRCA1-linked breast cancer

Amanda, F. Couch, P. Johnston, 2019 .

Establishing a molecular taxonomy for epithelial ovarian cancer (EOC) from 363 formalin-fixed paraffin embedded (FFPE) specimens.

T. Davison, D. Harrison, C. Gourley, 2011, Journal of Clinical Oncology.

Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue.

Sridhar Ramaswamy, Daniel J Sargent, Oliver F Bathe, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis

S. McDade, J. Blayney, Julia J. Gorski, 2011, Nucleic acids research.

Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer

F. Couch, M. Salto‐Tellez, T. Davison, 2014, Journal of the National Cancer Institute.

Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue.

T. Davison, M. Tsao, F. Shepherd, 2015, The Journal of molecular diagnostics : JMD.

Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

F. Couch, P. Johnston, W. Chung, 2007, Journal of the National Cancer Institute.

BRCA1 Regulates IFN-γ Signaling through a Mechanism Involving the Type I IFNs

P. Mullan, Julia J. Gorski, D. Harkin, 2007, Molecular Cancer Research.

Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).

R. Schilsky, M. Bertagnolli, T. Davison, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification and validation of an assay predictive of response and prognosis following anthracycline-based chemotherapy for early breast cancer.

F. Couch, M. Salto‐Tellez, T. Davison, 2013 .

Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21.

G. Campiani, D. Zisterer, A. Ramunno, 2003, Biochimica et Biophysica Acta.

Analytical Performance of a Formalin-fixed Paraffin-embedded Tissue-based 634-probe Prognostic Assay for Predicting Outcome of Patients With Stage II Colon Cancer

Shuguang Huang, A. Bennett, Dakun Wang, 2014, Applied immunohistochemistry & molecular morphology : AIMM.

Response: Re: Molecular Basis for Estrogen Receptor α Deficiency in BRCA1-Linked Breast Cancer

F. Couch, W. Chung, A. McCann, 2007 .

Molecular Basis for Estrogen Receptor α Deficiency in BRCA1-Linked Breast Cancer

F. Couch, P. Mullan, D. Harkin, 2007 .

The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivo.

G. Campiani, D. Williams, D. Zisterer, 2005, Oncology reports.

Generation of a non-small cell lung cancer transcriptome microarray

D. Harkin, A. Tanney, V. Proutski, 2008, BMC Medical Genomics.

Molecular Basis for Estrogen Receptor α Deficiency in BRCA1-Linked Breast Cancer

F. Couch, P. Mullan, D. Harkin, 2007 .

Reply to L. Casadaban et al.

R. Schilsky, M. Bertagnolli, T. Davison, 2017, Journal of Clinical Oncology.